(Q28367510)

English

Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans (English)

0 references

1 reference

J C Fleishaker

1

0 references

K K Ryan

series ordinal

2

0 references

J M Jansat

series ordinal

3

0 references

B J Carel

series ordinal

4

0 references

D J Bell

series ordinal

5

0 references

M T Burke

series ordinal

6

0 references

N E Azie

series ordinal

7

0 references

language of work or name

English

0 references

publication date

May 2001

0 references

published in

British Journal of Clinical Pharmacology

0 references

volume

51

0 references

issue

5

0 references

page(s)

437-41

0 references

cites work

Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90)

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014480

retrieved

20 March 2017

The role of cytochrome P450 2D6 in the metabolism of moclobemide

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014480

retrieved

20 March 2017

Evaluation of the potential pharmacokinetic interaction between almotriptan and fluoxetine in healthy volunteers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014480

retrieved

29 September 2017

The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014480

retrieved

29 September 2017

Serotonin and migraine

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014480

retrieved

29 September 2017

Serotonin receptor and reuptake sites: pharmacologic significance

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014480

retrieved

29 September 2017

Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: A panel study*

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2001.01367.X

retrieved

21 January 2018

Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11422001

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11422001

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1046/J.1365-2125.2001.01367.X

0 references

Fatcat ID

release_6ghzppjbw5acteuqq33pbgcyey

0 references

PMC publication ID

2014480

0 references

PubMed publication ID

11422001

0 references

ResearchGate publication ID

11918469

0 references

(Q28367510)

Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)